Block Listing Update

RNS Number : 5299P

Futura Medical PLC

02 October 2013

 



For immediate release

2 October 2013

Futura Medical plc

("Futura" or "the Company")

Block Listing Update

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, in the six months since the previous block admission update on 22 May 2013 the following changes have taken place:

Futura Medical plc Option Plan	Block Listed 25 May 2011	Block Listing Brought Forward	Options Exercised in Period	Options Added to Block Listing In Period	Block Listing Carried Forward
Unapproved Share Option Scheme	814,424	684,155	-	1,193,959	1,878,114
EMI Share Option Scheme	1,520,576	548,086	(135,000)	1,476,041	1,889,127
	2,335,000	1,232,241	(135,000)	2,670,000	3,767,241

An application has been made to the London Stock Exchange for the block admission of a further 2,670,000 ordinary shares of 0.2p pence each ("Ordinary Shares") to be admitted to trading on AIM. The new shares expected to be admitted pursuant to the above application shall rank pari passu with the existing issued Ordinary Shares of the Company. It is expected that admission will become effective on 8 October 2013.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Cenkos Securities plc
Bobbie Hilliam	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

MSCUGGPAUUPWUBP